MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote (indian pharma)
- TORRENT PHARMA
TORRENT PHARMA Share Price (TORR)
Here is the latest stock price and chart of Torrent Pharma. For more details, see the Torrent Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Airs Tomorrow at 5pm: The Instant Income Summit
| Live BSE Quotes | Jan 20, 2020 03:37:00 PM | ||
|---|---|---|---|
| Price (Rs)2,029.70 | Open (Rs) 2,007.00 | High (Rs) 2,072.60 | Low (Rs) 1,988.85 |
| % Change1.15 | Volume 16,573 | Value (Rs) 33,638,218 | 52-Week H/L 2,028.00 / 1,453.00 |
| Live NSE Quotes | Jan 20, 2020 3:29:58 PM | ||
|---|---|---|---|
| Price (Rs)2,023.10 | Open (Rs) 2,006.35 | High (Rs) 2,073.65 | Low (Rs) 1,985.55 |
| % Change0.83 | Volume 889,585 | Value (Rs) 1,812,653,979 | 52-Week H/L 2,028.00 / 1,452.00 |
| Valuation | |||
|---|---|---|---|
| EPS (Rs)* 32.73 | P/E Ratio (x) 62.01 | Market Cap (Rs m) 343,547.02 | P/BV (x) 7.27 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
- Charts
-
S&P BSE SENSEX 
PERIOD - Advanced Charts new
- Charts by TradingView
TORRENT PHARMA Share Price Today:
TORRENT PHARMA share price has hit a 52-week high. It's last traded price had surged 1.2% to Rs 2,029.7 on the BSE. On the NSE, TORRENT PHARMA last traded price had surged 0.8% to Rs 2,023.1. The total volume of shares traded was 0.9 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 0.4%. And the benchmark S&P BSE SENSEX was at 41,545.8 (down 1.0%).
Over the last 30 days, the TORRENT PHARMA share price is up 10.7%. And over the last one year, TORRENT PHARMA share price is up 7.5%.
Today's Market
Sensex Ends 416 Points Lower; Banking and Energy Stocks Witness Huge Selling(Closing)
After hitting record highs in the morning trade today, India share markets gave up all the gains and ended near day's low with Nifty below 12,250 level.
Related Views On News
TORRENT PHARMA at All Time High; BSE HEALTHCARE Index Down 0.1% (Market Updates)
Jan 20, 2020 | Updated on Jan 20, 2020TORRENT PHARMA share price has hit an all time high at Rs 2,073 (up 2.9%). The BSE HEALTHCARE Index is down by 0.1%. Among the top gainers in the BSE HEALTHCARE Index today are TORRENT PHARMA (up 2.9%) and ABBOTT INDIA (up 0.1%). The top losers include CADILA HEALTHCARE (down 0.2%) and WOCKHARDT (down 0.3%).
TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)
Nov 1, 2019 | Updated on Nov 1, 2019For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.
TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)
Jul 25, 2019 | Updated on Jul 25, 2019For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.
Aster DM Healthcare (IPO)
Feb 10, 2018Should you subscribe to the IPO of Aster DM Healthcare Ltd?
More Views on NewsMost Popular
My Latest Stock Recommendation (Fast Profits Daily)
Jan 10, 2020The story behind my latest stock recommendation and an important announcement.
Saffron Curtain = Hindutva Rate of Growth? (The Honest Truth)
Jan 8, 2020Will the Indian economy revert to a sub-3% growth rate?
Your Safe Income Options for 2020 (Fast Profits Daily)
Jan 9, 2020What are you safest investing options in 2020 when interest rates fall.
Bet on These Smallcap Stocks for Success in 2020 (Profit Hunter)
Jan 14, 2020The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.
Guess Which Stocks Are Rising at Double the Speed of Sensex (Profit Hunter)
Jan 15, 2020These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.
MoreOUR TOP 5 IDEAS
- Free Guide on How to Profit from Sensex 100,000.
- A Simple Test to Find out If a Stock Has 100x Potential
- A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Revealed: Top 7 Stocks to Consider Buying Right Now...
TRACK TORRENT PHARMA
- Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON TORRENT PHARMA
TORRENT PHARMA - TEVA PHARMA COMPARISON
COMPARE TORRENT PHARMA WITH
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.